UNIVERSITY OF MINNESOTA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1851-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.umn.edu
Evaluation of the SCALED (SCaling AcceptabLE cDs)
Recruiting
- Conditions
- Traumatic Brain InjuryVenous Thromboembolism
- Interventions
- Other: Observational-controlOther: Observational
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 15000
- Registration Number
- NCT05628207
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
Recruiting
- Conditions
- Anal Cancer
- Interventions
- Other: Observational/Survery
- First Posted Date
- 2022-11-28
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 5000
- Registration Number
- NCT05628194
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Prevention and Screening for Early Detection of HPV-related Cancers in Gay and Bisexual Men in Tanzania
Not Applicable
Completed
- Conditions
- HPV
- Interventions
- Other: Training on self-screening and HPV vaccination administration
- First Posted Date
- 2022-11-15
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 83
- Registration Number
- NCT05616767
- Locations
- 🇹🇿
Dar es Salaam, Dar es Salaam, Tanzania
Testing A Visual Thermometer in Newborns and Young Infants
Completed
- Conditions
- HyperthermiaHypothermia
- Interventions
- Device: observational
- First Posted Date
- 2022-11-08
- Last Posted Date
- 2023-11-28
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 120
- Registration Number
- NCT05609292
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
Phase 3
Recruiting
- Conditions
- COVID-19
- Interventions
- Drug: Shionogi Protease Inhibitor (S-217622)Drug: placebo
- First Posted Date
- 2022-11-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 1500
- Registration Number
- NCT05605093
- Locations
- 🇲🇽
Instituto Nacional de Enfermedades Respiratorias Ismael Cosió Villegas (Site 653-002), Mexico City, Cdmx, Mexico
🇦🇺St. Vincent's Hospital (Site 612-002), Sydney, New South Wales, Australia
🇦🇺Westmead Hospital (Site 612-058), Westmead, New South Wales, Australia
TDCS-potentiated Generalization of Cognitive Training in the Rehabilitation of Long COVID Symptoms
Not Applicable
Withdrawn
- Conditions
- Post-acute Sequelae SARS-CoV-2 Infection (PASC)
- Interventions
- Other: Active tDCSOther: Sham tDCS
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- University of Minnesota
- Registration Number
- NCT05589272
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)
Recruiting
- Conditions
- Gaucher Disease, Type 3
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 5
- Registration Number
- NCT05586243
- Locations
- 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
Udall Project 1 Aim 4
Recruiting
- Conditions
- Deep Brain StimulationParkinsons Disease
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 100
- Registration Number
- NCT05568199
- Locations
- 🇺🇸
University Of Minnesota, Minneapolis, Minnesota, United States
Combining tDCS and CILT in Non-fluent Aphasia
Not Applicable
Completed
- Conditions
- StrokeAphasiaNon-fluent AphasiaBrain Injuries
- Interventions
- Other: PlaceboDevice: tDCS
- First Posted Date
- 2022-09-30
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 5
- Registration Number
- NCT05561400
- Locations
- 🇺🇸
University of Minnesota, Duluth, Minnesota, United States
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
Not Applicable
Recruiting
- Conditions
- Parkinson's Disease
- Interventions
- Device: Deep Brain Stimulation
- First Posted Date
- 2022-09-28
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- University of Minnesota
- Target Recruit Count
- 24
- Registration Number
- NCT05557864
- Locations
- 🇺🇸
University Of Minnesota, Minneapolis, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath